Orphazyme is now officially in American hands
The sale of embattled biotech firm Orphazyme to US-based Kempharm is now complete.
by stefan nygaard hansen, translated by catherine brett
Orphazyme has announced that the sale of the firm and all of its assets to Kempharm is now complete.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
.jpg)
Future uncertain for Orphazyme CEO as firm sold
For subscribers
Orphazyme didn't know buyer before negotiations began
For subscribers
